# Impact of Two Guided Transfusion Strategies on Blood Product Requirements in Liver Transplantation.

> **NCT04405518** · PHASE4 · UNKNOWN · sponsor: **Antoni Sabaté Pes** · enrollment: 188 (actual)

## Conditions studied

- Fibrin Blood Clot

## Interventions

- **DRUG:** Fibrinogen Concentrate (Human) 1 MG [RiaSTAP]

## Key facts

- **NCT ID:** NCT04405518
- **Lead sponsor:** Antoni Sabaté Pes
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-17
- **Primary completion:** 2021-11-02
- **Final completion:** 2022-10-31
- **Target enrollment:** 188 (ACTUAL)
- **Last updated:** 2021-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04405518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04405518, "Impact of Two Guided Transfusion Strategies on Blood Product Requirements in Liver Transplantation.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04405518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*